Income Statement (TTM)
Apontis Pharma AG Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 39 | 42 | 46 | 48 | 51 | 54 | 56 | 56 | 56 | 51 | 46 | 42 | 37 | 39 | 41 | 45 | 48 | 50 | 52 |
| Change (%) | 8.09 | 7.48 | 6.14 | 5.78 | 4.54 | 4.34 | -0.09 | -0.09 | -8.61 | -9.43 | -9.93 | -11.03 | 4.96 | 4.73 | 9.64 | 8.79 | 3.41 | 3.30 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 14 | 15 | 16 | 17 | 17 | 19 | 20 | 20 | 21 | 19 | 17 | 15 | 14 | 15 | 16 | 18 | 21 | 21 | 22 |
| Change (%) | 7.67 | 7.13 | 3.05 | 2.96 | 6.83 | 6.39 | 2.43 | 2.38 | -9.51 | -10.51 | -8.92 | -9.80 | 6.98 | 6.53 | 16.05 | 13.83 | 2.15 | 2.11 | |
| % of Revenue | 36.23 | 36.09 | 35.97 | 34.92 | 33.99 | 34.73 | 35.42 | 36.31 | 37.21 | 36.84 | 36.40 | 36.81 | 37.32 | 38.03 | 38.69 | 40.95 | 42.84 | 42.32 | 41.84 |
| Gross Operating Profit | 25 | 27 | 29 | 31 | 34 | 35 | 36 | 36 | 35 | 32 | 29 | 26 | 23 | 24 | 25 | 26 | 28 | 29 | 30 |
| Change (%) | 8.32 | 7.68 | 7.87 | 7.30 | 3.36 | 3.25 | -1.48 | -1.50 | -8.08 | -8.79 | -10.51 | -11.74 | 3.76 | 3.62 | 5.60 | 5.30 | 4.35 | 4.17 | |
| % of Revenue | 63.77 | 63.91 | 64.03 | 65.08 | 66.01 | 65.27 | 64.58 | 63.69 | 62.79 | 63.16 | 63.60 | 63.19 | 62.68 | 61.97 | 61.31 | 59.05 | 57.16 | 57.68 | 58.16 |
| SG&A | 18 | 20 | 22 | 21 | 20 | 18 | 17 | 19 | 20 | 21 | 21 | 21 | 21 | 19 | 18 | 16 | 15 | 15 | 16 |
| Change (%) | 9.73 | 8.86 | -4.45 | -4.66 | -6.39 | -6.83 | 8.64 | 7.95 | 2.93 | 2.85 | -0.94 | -0.95 | -7.85 | -8.51 | -7.59 | -8.21 | 2.56 | 2.50 | |
| % of Revenue | 46.21 | 46.91 | 47.52 | 42.78 | 38.55 | 34.52 | 30.83 | 33.52 | 36.22 | 40.80 | 46.33 | 50.95 | 56.72 | 49.80 | 43.50 | 36.67 | 30.94 | 30.68 | 30.45 |
| R&D | |||||||||||||||||||
| Change (%) | |||||||||||||||||||
| % of Revenue | |||||||||||||||||||
| OpEx | 40 | 44 | 48 | 47 | 47 | 46 | 45 | 49 | 52 | 51 | 50 | 48 | 47 | 45 | 44 | 46 | 47 | 49 | 51 |
| Change (%) | 10.05 | 9.13 | -1.15 | -1.16 | -1.74 | -1.77 | 7.40 | 6.89 | -2.18 | -2.23 | -3.10 | -3.20 | -2.42 | -2.48 | 3.30 | 3.19 | 3.71 | 3.58 | |
| % of Revenue | 101.83 | 103.68 | 105.27 | 98.04 | 91.60 | 86.10 | 81.05 | 87.14 | 93.23 | 99.79 | 107.72 | 115.90 | 126.09 | 117.22 | 109.15 | 102.83 | 97.53 | 97.82 | 98.08 |
| Operating Income | -1 | -2 | -2 | 1 | 4 | 7 | 11 | 7 | 4 | 0 | -4 | -7 | -10 | -7 | -4 | -1 | 1 | 1 | 1 |
| Change (%) | 116.96 | 53.91 | -139.52 | 353.06 | 73.02 | 42.20 | -32.16 | -47.41 | -97.22 | -3,491.83 | 85.33 | 46.04 | -30.73 | -44.36 | -66.07 | -194.73 | -8.48 | -9.27 | |
| % of Revenue | -1.83 | -3.68 | -5.27 | 1.96 | 8.40 | 13.90 | 18.95 | 12.86 | 6.77 | 0.21 | -7.72 | -15.90 | -26.09 | -17.22 | -9.15 | -2.83 | 2.47 | 2.18 | 1.92 |
| Interest Expense | -1 | -1 | -1 | -1 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||
| Change (%) | -1.17 | -1.19 | -25.76 | -40.12 | -50.81 | 100.00 | -0.00 | -4.83 | 219.64 | 68.72 | -0.00 | 6.62 | -58.62 | ||||||
| % of Revenue | -2.05 | -1.88 | -1.73 | -1.21 | -0.68 | -0.32 | -0.02 | -0.05 | -0.05 | -0.05 | -0.16 | -0.27 | -0.24 | -0.24 | -0.09 | ||||
| Net Income | -1 | -1 | -1 | -1 | -1 | 2 | 4 | 3 | 3 | -0 | -3 | -7 | -11 | -9 | -7 | -3 | 1 | 1 | 1 |
| Change (%) | 10.24 | 9.29 | -23.86 | -31.33 | -305.15 | 148.74 | -14.65 | -17.16 | -109.21 | 1,186.01 | 127.50 | 56.04 | -18.69 | -22.98 | -55.32 | -123.83 | -6.57 | -7.03 | |
| % of Revenue | -3.01 | -3.07 | -3.13 | -2.24 | -1.46 | 2.86 | 6.81 | 5.82 | 4.82 | -0.49 | -6.90 | -17.44 | -30.58 | -23.69 | -17.42 | -7.10 | 1.55 | 1.40 | 1.26 |
Source: Capital IQ
